Navigation Links
Venaxis' APPY1 Test Passes Futility Analysis in Pivotal Clinical Study
Date:7/15/2013

on our commercial milestones in Europe, where we are preparing to initiate economic outcomes studies at leading hospitals.  Importantly, with our recent financing, we have sufficient capital to achieve major regulatory and commercial milestones.  While we remain prudent with the use of cash, we see no financial obstacles to reaching these significant value inflection points."

Venaxis strengthened its financial position with an additional $14.4 million in gross proceeds from a May public offering led by Piper Jaffray & Company.  The Company currently estimates cash, cash equivalents, and short-term investments to be approximately $20 million at the close of the second quarter 2013, which will be reflected in the Company's Form 10-Q to be filed in the coming weeks.  

Don Hurd, Senior Vice President and Chief Commercial Officer of Venaxis, stated, "We remain on track for a full-scale European launch for the APPY1 Test beginning in the fourth quarter of this year.  We currently have four market development agreements in place and we are in the final process of selecting partners in additional target countries, including Germany, the UK, and France.  In terms of our existing partner agreements, we are initiating and expect to complete several outcome studies by the end of the third quarter 2013 and anticipate leveraging robust data from those studies to demonstrate objectively the clinical and economic value of using the APPY1 Test in the hospital emergency room. We remain focused on laying a solid foundation as we continue onto full-scale commercialization of APPY1 in Europe and advance to commercialization in the United States."

Conference Call Information
The Company has scheduled its quarterly conference call and webcast f
'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Venaxis Announces Pricing of Offering of Common Stock and Warrants
2. Venaxis Executes First Commercial Development Agreement and Receives Purchase Order from EMELCA Bioscience for Initial EU Launch
3. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
4. Eastern Clinical Trials Russia CRO Passes EMA Inspection
5. Legendary Author And Screenwriter Nora Ephron Passes Away At 71; Solar Cigarette Pays Tribute To Such A Rare Talent
6. Butamax Early Adopters Group surpasses capacity targets with addition of Big River; Membership represents 11 production facilities and nearly 900 million gallons of ethanol capacity
7. Free Expo-Hall Passes for ATA 2012
8. Accuray Surpasses 600 Installations Globally
9. Unisense FertiliTech to Present Large Scale Time-lapse Data Analysis to Improve IVF Treatment
10. New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
11. Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 CytomX, a biotechnology ... today announced that Sean McCarthy , D. Phil., ... Antibody Day in New York ... McCarthy will present an overview of CytomX,s Probody pipeline, ... conjugate programs. About CytomX Therapeutics CytomX ...
(Date:5/5/2015)... May 5, 2015  Indianapolis-based medical device manufacturer ... innovative line of products including the BrainPath® and ... accessing deep-seated brain abnormalities and then removing affected ... at more than 50 institutions throughout ... also been included in 12 abstracts, three peer-reviewed ...
(Date:5/4/2015)... JSS Medical Research Inc., a Montreal based ... of Max Neeman International (MNI), with head office in ... Ahmedabad, Bangalore , Chennai ... regional office is located North Carolina, USA . ... equity investment transaction into JSS with Capital Croissance PME (CCPME), a ...
(Date:5/4/2015)... 2015 /PRNewswire/ - Fluorinov Pharma (Fluorinov), a FACIT ... of Dr. Roger J Garceau, to its Board ... in matters including corporate development and clinical strategy, ... significant regulatory expertise as Fluorinov transitions to clinical ... years of pharmaceutical development experience to Fluorinov and ...
Breaking Biology Technology:NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 2Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 3
... BEIJING, Aug. 14 /PRNewswire-Asia-FirstCall/ -- Lotus ... growing developer and,producer of prescription drugs and licensed national seller ... financial results,for the quarter and six months ended June 30, ... Highlights and Developments:, -- Q2 diluted EPS ...
... HARBIN, China, Aug. 14 /PRNewswire-Asia-FirstCall/ -- ... Company") (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... financial results for the second quarter,of 2009. , , ... Total revenues increased 35.5% year-over-year to $32.2 million, ...
... ... for ISP,s Vincience™ Biofunctional Ingredients, Rapidly and Effectively , ... (PRWEB) August 14, 2009 -- ... global supplier of advanced personal care ingredients, announced that they have formed an ...
Cached Biology Technology:Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 2Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 3Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 4Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 5Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 6Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 7Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 8Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 9Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 10Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results 11China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 2China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 3China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 4China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 5China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 6China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 7China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 8China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 9China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 10China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 11Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics-Based Computer Modeling of Skin Biology 2Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics-Based Computer Modeling of Skin Biology 3Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics-Based Computer Modeling of Skin Biology 4
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... , April 2, 2015 At its 2015 ... Lake City , the American College of Medical ... new directors to its Board.  Members of the ACMG ... and for forming and advancing its policies and programs. ... profession. "It,s an eventful time in medical ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... University, in London, Canada, have developed a CT (Computed Tomography) ... Battista, Chair of the Department of Medical Biophysics at the ... the London Regional Cancer Program at London Health Sciences Centre ... interactive way to teach CT imaging techniques to a wide ...
... Research Institute (OHRI) and the University of Ottawa (uOttawa) has ... (CIHR) and $75,000 from the Stem Cell Network to lead ... cell therapy for septic shock. This deadly condition occurs when ... system, resulting in severe organ damage and death in 30 ...
... Epigenetics is the new hip science. Time Magazine,s front cover ... explains why. Its more explicit subtitle provided the hook - ,The ... change your genes - and those of your kids,. Who ... ways in which the genetic code in our DNA is regulated ...
Cached Biology News:Mini-CT scanner developed as a teaching tool 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 3Epigenetics and epidemiology -- hip, hype and science 2Epigenetics and epidemiology -- hip, hype and science 3
anti-Lactate Dehydrogenase...
6-keto Prostaglandin F1α EIA Antiserum 6-keto-PGF1alpha EIAs prostaglandins antisera enzyme immunoassays reagents 6-keto-PGF1.alpha....
... developed for use with immunohistochemical (IHC) ... background staining due to endogenous peroxidase. ... with hydrogen peroxide. This reagent ... additional novel components to further quench ...
Phospho-Btk (Tyr223) Antibody...
Biology Products: